Ellen Chadwick

  • Professor, Pediatrics
  • Susan B. DePree Founders' Board Professor in Pediatric Adolescent and Maternal HIV Infection, Pediatrics
  • 2885 Citations
1983 …2021
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Dr. Chadwick is Irene Heinz Given and John LaPorte Given Chair in Pediatrics, Director of the Section of Pediatric, Adolescent and Maternal HIV Infection and attending physician in Pediatric Infectious Diseases at the Ann & Robert H. Lurie Children's Hospital of Chicago. She is Professor of Pediatrics at Northwestern Feinberg School of Medicine. She joined the Northwestern faculty in 1985 after completing her pediatric residency and fellowship in Pediatric Infectious Diseases at Children's Memorial Hospital at the McGaw Medical Center of Northwestern University.

Dr. Chadwick's research career has been focused on the field of Pediatric HIV/AIDS. As a member of the NIH-funded International Maternal Pediatric Adolescent AIDS Clinical Trial (IMPAACT) network, she is chairperson of domestic and international protocols investigating the pharmacokinetics, pharmacogenomics and efficacy of new antiretroviral agents and approaches to therapy and early intensive therapy to achieve remission in HIV-infected infants, and Vice-Chair of the Cure Research Agenda Committee. She serves as Co-Principal Investigator of the NIH-funded Pediatric HIV/AIDS Cohort Study (PHACS), a prospective longitudinal cohort study investigating the long-term effects of HIV infection and antiretroviral medications in mother/infant pairs and young adults who were born with HIV or perinatally exposed to HIV. This prospective longitudinal study follows >3000 newborns, young children, adolescents, young adults. She chairs the American Academy of Pediatrics Committee on Pediatric AIDS, and is a member of the U.S. Dept of Health and Human Services Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV.

I am a Pediatric Infectious Diseases Specialist who cares for infants, children and adolescents living with or exposed to HIV infection. As the primary pediatric consultant to the 24/7 Illinois Perinatal HIV Hotline, I advise obstetric and pediatric providers on the management of perinatally HIV-exposed newborns. In response to the growth of Pediatric AIDS in international settings, I have traveled to several African nations to train physicians about prevention of mother to child transmission of HIV and the management of antiretroviral therapy for children and adolescents living with HIV.

Certifications and Licenses

Pediatric Infectious Diseases

Training Experience

1982Residency, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital)
1985Fellowship, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital)

Education/Academic qualification

MD, University of Virginia

… → 1979

Research interests

  • AIDS
  • Infectious Diseases
  • Medical Education
  • Pediatrics

Fingerprint Dive into the research topics where Ellen Chadwick is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles
HIV Medicine & Life Sciences
Ritonavir Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Lopinavir Medicine & Life Sciences
HIV-1 Medicine & Life Sciences
HIV Infections Medicine & Life Sciences
Preschool Children Medicine & Life Sciences
Acquired Immunodeficiency Syndrome Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1983 2019

Association between zidovudine-containing antiretroviral therapy exposure in utero and leukocyte telomere length at birth

Wang, Y., Brummel, S. S., Beilstein-Wedel, E., Dagnall, C. L., Hazra, R., Kacanek, D., Chadwick, E., Marsit, C. J., Chanock, S. J., Savage, S. A., Poirier, M. C., Machiela, M. J. & Engels, E. A., Nov 1 2019, In : AIDS. 33, 13, p. 2091-2096 6 p.

Research output: Contribution to journalArticle

Implosive Therapy

Establishing Dosing Recommendations for Efavirenz in HIV/TB-Coinfected Children Younger Than 3 Years

Bwakura Dangarembizi, M., Samson, P., Capparelli, E. V., Moore, C. B., Jean-Philippe, P., Spector, S. A., Chakhtoura, N., Benns, A., Zimmer, B., Purdue, L., Jackson, C., Wallis, C., Libous, J. L. & Chadwick, E., Aug 1 2019, In : Journal of Acquired Immune Deficiency Syndromes. 81, 4, p. 473-480 8 p.

Research output: Contribution to journalArticle

Area Under Curve
1 Citation (Scopus)

Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration

The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, Feb 1 2019, In : The Lancet HIV. 6, 2, p. e105-e115

Research output: Contribution to journalArticle

Protease Inhibitors
Reverse Transcriptase Inhibitors

Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine

Rough, K., Seage, G. R., Williams, P. L., Hernandez-DIaz, S., Huo, Y., Chadwick, E., Currier, J. S., Hoffman, R. M., Barr, E., Shapiro, D. E. & Patel, K., Sep 1 2018, In : Obstetrical and Gynecological Survey. 73, 9, p. 513-515 3 p.

Research output: Contribution to journalComment/debate

Pregnant Women
8 Citations (Scopus)

Birth outcomes for pregnant women with HIV using tenofovir–Emtricitabine

for the PHACS and the IMPAACT P1025 Study Teams, Apr 26 2018, In : New England Journal of Medicine. 378, 17, p. 1593-1603 11 p.

Research output: Contribution to journalArticle

Premature Birth
Pregnant Women